 Sage Therapeutics, Inc. NASDAQ:SAGE Q3 2022 Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants Helen Rubinstein - Director, IR Barry Greene - Chief Executive Officer Kimi Iguchi - Chief Financial Officer Jim Doherty - Chief Development Officer Chris Benecchi - Chief Business Officer Jeff Jonas - Chief Innovation Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler Ritu Baral - Cowen Salveen Richter - Goldman Sachs Paul Matteis - Stifel Laura Chico - Wedbush Jay Olson - Oppenheimer Ami Fadia - Needham Company Sumant Kulkarni - Canaccord Genuity Joon Lee - Truist Operator Good morning. Welcome to the Sage Therapeutics Third Quarter 2022 Financial Results Conference Call. 